HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teresa Escalante Selected Research

Bothrops jararaca Venom

9/2005Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxin.
7/2005Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage.
11/2003Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothrops jararaca snake venom.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teresa Escalante Research Topics

Disease

20Hemorrhage
07/2021 - 04/2002
9Snake Bites (Snake Bite)
07/2022 - 11/2006
4Thrombocytopenia (Thrombopenia)
07/2022 - 02/2004
4Edema (Dropsy)
07/2021 - 04/2002
4Wounds and Injuries (Trauma)
10/2020 - 11/2009
3Inflammation (Inflammations)
07/2021 - 09/2005
3Necrosis
03/2021 - 09/2005
2Shock
10/2020 - 12/2009
2Blister (Bulla)
01/2019 - 10/2008
2Hypovolemia
01/2015 - 12/2009
1Disseminated Intravascular Coagulation
07/2022
1Acute Lung Injury
07/2021
1Myotoxicity
01/2018
1Atrophy
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Thrombosis (Thrombus)
03/2013
1Bacterial Infections (Bacterial Infection)
12/2009
1Ischemia
12/2009
1Rupture
01/2006

Drug/Important Bio-Agent (IBA)

17Metalloproteases (Metalloproteinases)IBA
07/2021 - 11/2003
15VenomsIBA
07/2022 - 02/2004
15Snake Venoms (Snake Venom)IBA
07/2021 - 11/2003
9Proteins (Proteins, Gene)FDA Link
07/2021 - 09/2005
4Collagen Type IV (Type IV Collagen)IBA
03/2021 - 10/2008
3EnzymesIBA
07/2021 - 12/2009
3Laminin (Merosin)IBA
03/2021 - 10/2008
3Antivenins (Antivenoms)IBA
01/2021 - 01/2012
3Peptide Hydrolases (Proteases)FDA Link
01/2019 - 11/2003
3batimastat (BB 94)IBA
10/2008 - 04/2002
3Bothrops jararaca VenomIBA
09/2005 - 11/2003
2Extracellular Matrix ProteinsIBA
08/2011 - 11/2009
2estropipate (Ogen)FDA LinkGeneric
12/2009 - 07/2005
2PeptidomimeticsIBA
03/2004 - 04/2002
1Pentoxifylline (Trental)FDA LinkGeneric
07/2021
1Indomethacin (Indometacin)FDA LinkGeneric
07/2021
1Complement System Proteins (Complement)IBA
01/2021
1ProteomeIBA
01/2019
1CoagulantsIBA
10/2016
1perlecanIBA
04/2016
1Collagen Type VIIBA
04/2015
1nidogen (entactin)IBA
04/2015
1FibrinIBA
03/2013
1Fibrinogen (Factor I)FDA Link
03/2013
1Immunoglobulin G (IgG)IBA
01/2012
1Peptides (Polypeptides)IBA
04/2011
1Biomarkers (Surrogate Marker)IBA
04/2011
1C-Type Lectins (C-Type Lectin)IBA
12/2009
1Hemostatics (Antihemorrhagics)IBA
12/2009
1ApolipoproteinsIBA
11/2009
1Phospholipases (Phospholipase)IBA
11/2009
1Fibrillar CollagensIBA
11/2009
1Non-Fibrillar CollagensIBA
11/2009
1Phospholipases A2 (Phospholipase A2)IBA
11/2009
1Fibronectins (Fibronectin)IBA
11/2009
1Apolipoproteins AIBA
11/2009
1Saline SolutionIBA
01/2006
1Interleukin-8 (Interleukin 8)IBA
09/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2005
1Interleukin-1beta (Interleukin 1 beta)IBA
09/2005
1Interleukin-6 (Interleukin 6)IBA
09/2005
1aspercetinIBA
07/2005
1Blood Proteins (Serum Proteins)IBA
11/2003
1Metallothionein 3IBA
04/2002
1Matrix Metalloproteinases (MMPs)IBA
04/2002
1Matrix Metalloproteinase InhibitorsIBA
04/2002

Therapy/Procedure

2Intravenous Injections
07/2021 - 07/2005
2Intravenous Administration
07/2005 - 02/2004
1Therapeutics
01/2021
1Lasers (Laser)
09/2005